Join Novogene and industry partners on July 31 for an afternoon of networking with scientists, biopharma leaders, and life science professionals across the RTP community. Enjoy co ...

Gene therapy legend R. Jude Samulski, Ph.D., co-founder and chief scientific officer of Asklepios BioPharmaceutical (AskBio) since the company was established in 2001, is leaving the CSO job but ...

Raleigh-based Marius Pharmaceuticals, led by several former GlaxoSmithKline scientists and executives, is making progress on its first potential drug. Marius has submitted a New Drug Application (NDA) ...

Durham-based Atsena Therapeutics, a clinical-stage gene therapy company focused on using genetic medicine to reverse or prevent blindness, has dosed the first patient in the Phase 3 pivotal cohort of ...

Caidya, a global clinical research organization based in Raleigh, has announced it is combining with UK-based CRO ...

Join us in Research Triangle Park (RTP) for lunch, expert presentations, and networking focused on accelerating complex drug development. Stick around for the RTP Roadshow—a half-day symposium ...

Durham-based 410 Medical, a medical device company developing new technologies for emergency and critical care, has raised ...

I had the opportunity to participate in a panel discussion reflecting on my experiences working with both EBRC and the ...

Clean Cells, a France-based provider of quality testing services for biopharmaceutical products, will acquire Stem Genomics, ...

More than 100 Research Triangle Park officials and other supporters gathered on Thursday for a celebration at HUB RTP to mark ...

Building on initial successes, the program got a significant funding boost in 2022 with the Accelerate NC - Life Sciences Manufacturing initiative. Accelerate NC, led by NCBiotech, was funded by a $25 ...

Pathalys Pharma, a Research Triangle Park-based biopharmaceutical company developing therapies for end-stage kidney disease, has secured $150 million in new financing to support phase 3 clinical ...